P Rod Dunbar

P Rod Dunbar

University of Auckland

H-index: 65

Oceania-New Zealand

About P Rod Dunbar

P Rod Dunbar, With an exceptional h-index of 65 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Auckland, specializes in the field of immunology, cancer, stem cells.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

Highly efficient CRISPR/Cas9‐mediated exon skipping for recessive dystrophic epidermolysis bullosa

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression

Rapid culture of human keratinocytes in an autologous, feeder-free system with a novel growth medium

Tissue culture apparatus and method

Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections

Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses

P Rod Dunbar Information

University

Position

Director Maurice Wilkins Centre & Professor School of Biological Sciences

Citations(all)

21087

Citations(since 2020)

3885

Cited By

18586

hIndex(all)

65

hIndex(since 2020)

30

i10Index(all)

144

i10Index(since 2020)

96

Email

University Profile Page

Google Scholar

P Rod Dunbar Skills & Research Interests

immunology

cancer

stem cells

Top articles of P Rod Dunbar

Title

Journal

Author(s)

Publication Date

Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection

JHEP Reports

Harry L Janssen

Young-Suk Lim

Hyung Joon Kim

Leonard Sowah

Cheng-Hao Tseng

...

2024/2/1

Highly efficient CRISPR/Cas9‐mediated exon skipping for recessive dystrophic epidermolysis bullosa

Bioengineering & Translational Medicine

Alex du Rand

John Hunt

Christopher Samson

Evert Loef

Chloe Malhi

...

2024/1/17

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Cancer Immunology, Immunotherapy

Nathaniel Dasyam

Katrina J Sharples

Catherine Barrow

Ying Huang

Evelyn Bauer

...

2023/7

Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression

Journal of hepatology

Edward J Gane

P Rod Dunbar

Anna E Brooks

Fangqiu Zhang

Diana Chen

...

2023/3/1

Rapid culture of human keratinocytes in an autologous, feeder-free system with a novel growth medium

Cytotherapy

Vaughan Feisst

Inken Kelch

Elliott Dunn

Eloise Williams

Sarah Meidinger

...

2023/2/1

Tissue culture apparatus and method

2023/10/31

Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections

Journal of Immunological Methods

Saem Mul Park

Chun-Jen J Chen

Joanna E Mathy

Shelly CY Lin

Richard CW Martin

...

2023/7/1

Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses

Journal of Biological Chemistry

Evert J Loef

Hilary M Sheppard

Nigel P Birch

P Rod Dunbar

2022/7/1

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect

Oncoimmunology

Kef K Prasit

Laura Ferrer-Font

Olivia K Burn

Regan J Anderson

Benjamin J Compton

...

2022/12/31

Amino acid and peptide conjugates and conjugation process

2020/10/1

S1189 Safety and Efficacy of Oral TLR8 Agonist, Selgantolimod, in Viremic Adult Patients With Chronic Hepatitis B

Official journal of the American College of Gastroenterology| ACG

Harry Janssen

Young-Suk Lim

Hyung Joon Kim

Cheng-Hao Tseng

Carla Coffin

...

2022/10/1

Migratory cues controlling B‐lymphocyte trafficking in human lymph nodes

Immunology and cell biology

Saem Mul Park

Anna ES Brooks

Chun‐Jen J Chen

Hilary M Sheppard

Evert Jan Loef

...

2021/1

Investigating the Individual Importance of the Pam2Cys Ester Motifs on TLR2 Activity

European Journal of Organic Chemistry

Benjamin L Lu

Freda F Li

Inken D Kelch

Geoffrey M Williams

P Rod Dunbar

...

2021/10/21

Amino acid and peptide conjugates and uses thereof

2021/5/25

A randomised trial of dentric cell vaccination with NY-ESO-1 and alpha-galactosylceramide in patients with metastatic melanoma (ACTRN12612001101875)

Cytotherapy

N Dasyam

K Sharples

C Barrow

E Bauer

B Mester

...

2021/5/1

Live-cell microscopy reveals that human T cells primarily respond chemokinetically within a CCL19 gradient that induces chemotaxis in dendritic cells

Frontiers in Immunology

Evert J Loef

Hilary M Sheppard

Nigel P Birch

P Rod Dunbar

2021/3/26

Neuroserpin regulates human T cell-T cell interactions and proliferation through inhibition of tissue plasminogen activator

Journal of Leukocyte Biology

Evert Jan Loef

Anna ES Brooks

Natalie Lorenz

Nigel P Birch

P Rod Dunbar

2020/1/1

Distinctive subpopulations of stromal cells are present in human lymph nodes infiltrated with melanoma

Cancer immunology research

Jennifer Eom

Saem Mul Park

Vaughan Feisst

Chun-Jen J Chen

Joanna E Mathy

...

2020/8/1

Dissecting adipose tissue derived mesenchymal stromal cell heterogeneity using single cell rna sequencing and multiparameter spectral flow cytometry

Cytotherapy

AE Brooks

AL Boss

K Lehnert

PR Dunbar

2020/5/1

Abstract B101: Molecular characteristics of tumor-associated macrophages in human melanoma metastases

Cancer Immunology Research

Saem Park

Anna Brooks

Chun-Jen Chen

Rod Dunbar

2020/3/1

See List of Professors in P Rod Dunbar University(University of Auckland)